Report cover image

Point of Care (PoC) Diagnostics Market Size, Share, Trends, & Industry Analysis Report By Product (Glucose Testing, Hb1Ac Testing, Coagulation), By Mode of Prescription, By End Use, and By Region – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Oct 01, 2025
SKU # PLRS20566066

Description

The Point-of-Care (PoC) diagnostics market size is expected to reach USD 137.11 billion by 2034, according to a new study by Polaris Market Research. The report “Point-of-Care (PoC) diagnostics Market Share, Size, Trends, Industry Analysis Report: By Product (Glucose Testing, Hb1Ac Testing, Coagulation), By Mode of Prescription, By End Use, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Point-of-Care (PoC) diagnostics are portable and patient-focused testing solutions designed to deliver real-time results outside traditional laboratory settings. The market is driven by the growing shift toward rapid and accurate testing solutions, which aligns directly with the essence of PoC diagnostics. PoC devices provide clinicians with immediate insights that enable timely interventions as healthcare systems continue to highlight faster decision-making. This transformation reduces dependency on centralized labs, improves efficiency in care delivery, and enhances patient outcomes by minimizing delays in diagnosis and treatment.

The PoC diagnostics market is further driven by the advancement of technology, which is redefining the precision and usability of these solutions. Breakthroughs in areas such as biosensors, connectivity, and miniaturization are making medical devices more reliable, portable, and user-friendly for both healthcare providers and patients. These innovations increase diagnostic accuracy and also allow seamless integration with digital health systems, supporting remote monitoring and data-driven healthcare. Together, these advancements are reinforcing the role of PoC diagnostics as a cornerstone of modern, patient-centric care delivery.

Point-of-Care (PoC) diagnostics Market Report Highlights

In terms of product, in 2024, infectious diseases held a 53.5% revenue share, driven by the critical need for rapid and accurate identification of communicable pathogens.

Based on mode of prescription, the OTC segment is expected to witness the fastest growth, fueled by rising consumer demand for self-testing kits for conditions like glucose and pregnancy.

North America led with a 31.4% global share in 2024, supported by its advanced, technology-focused healthcare infrastructure and widespread device accessibility.

The Asia Pacific market is projected to grow at 3.7% CAGR, driven by improving healthcare access and rising demand for affordable testing solutions.

A few global key market players include Abbott, BD, bioMérieux, Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, QuidelOrtho Corporation, Siemens Healthcare Private Limited, and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the market report on the basis of product, mode of prescription, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020–2034)

Glucose Testing

Hb1Ac Testing

Coagulation

Fertility

Infectious Diseases

HIV

Clostridium Difficile

HBV

Pneumonia or Streptococcus Associated Infections

Respiratory Syncytial Virus (RSV)

HPV

Influenza/Flu

HCV

MRSA

TB and Drug-Resistant TB

HSV

Others

Cardiac Markers

Thyroid Stimulating Hormone

Hematology

Primary Care Systems

Decentralized Clinical Chemistry

Feces

Lipid Testing

Cancer Marker

Blood Gas/Electrolytes

Ambulatory Chemistry

Drug Abuse Testing

Urinalysis

By Mode of Prescription (Revenue, USD Billion, 2020–2034)

OTC

Prescription-based

By End Use Outlook (Revenue, USD Billion, 2020–2034)

Clinics

Physician Office

Pharmacy & Retail Clinics

Non-practice Clinics

Urgent Care Clinic

Hospitals

Home

Assisted Living Healthcare Facilities

Laboratory

By Regional Outlook (Revenue, USD Billion, 2020–2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

Chapter 1. Introduction
1.1 Report Description
1.1.1 Objectives of the Study
1.2 Market segmentation& scope
1.2.1 Assumptions
1.2.2 Stakeholders
Chapter 2. Executive Summary
2.1 Market Highlights
Chapter 3. Research Methodology
3.1 Overview
3.1.1 Data Mining
3.2 Data Sources
3.2.1 Primary Sources
3.2.2 Secondary Sources
Chapter 4. Point of Care (PoC) Diagnostics Market Insights
4.1 Point of Care (PoC) Diagnostics – Industry snapshot
4.2 Point of Care (PoC) Diagnostics Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Introduction of CLIA waived tests
4.2.1.2 Growing Prevalence of Chronic and Infectious Diseases
4.2.1.3 Rising Advancement in PoC Technology
4.2.1.4 Growing geriatric population base
4.2.1.5 Growing prevalence of target diseases
4.2.1.6 Widespread adoption of RT-PCR Covid-19 testing and point-of care testing
4.2.1.7 Advent of New Technology
4.2.1.8 Growing demand for home healthcare and advent of advanced technology enabled products
4.2.2 Market Restraint Analysis
4.2.2.1 High procedure costs
4.2.2.2 Presence of ambiguous regulatory framework
4.3 Porter’s Five Forces Analysis
4.4 Point-of-Care Diagnostics– SWOT Analysis, By Factor (political & legal, economic and technological)
4.5 Competitive Landscape: Major market participants
4.5.1 Company size
4.5.2 Distribution network
4.5.3 Product portfolio
4.5.4 Segment coverage
4.5.5 Geographic presence
4.5.6 Collaborations
4.5.7 Conclusion
4.6 Product Positioning Analysis
4.6.1 Glucose testing
4.6.2 Hb1Ac testing
4.6.3 Coagulation testing
4.6.4 Fertility POC
4.6.5 Cardiac markers POC
4.6.6 Infectious disease POC diagnostics
4.6.7 Other point-of-care product segments
4.7 Marketing Channels
4.7.1 Abbott Diagnostics
4.7.1.1 Marketing Channels & Distribution Network
4.7.2 Roche Diagnostics
4.7.2.1 Marketing Channels & Distribution Network
4.7.3 Alere Inc.
4.7.3.1 Marketing Channels & Distribution Network
4.7.4 Siemens Healthcare
4.7.4.1 Marketing Channels & Distribution Network
4.7.5 Danaher Corporation
4.7.5.1 Marketing Channels & Distribution Network
4.7.6 Instrumentation Laboratory Spa.
4.7.6.1 Marketing Channels & Distribution Network
4.8 Point of Care (PoC) Diagnostics Market Industry trends
Chapter 5. Point of Care (PoC) Diagnostics Market Assessment by Product
5.1 Introduction
5.1 Glucose Testing
5.2 Hb1Ac Testing
5.3 Coagulation
5.4 Fertility
5.5 Cardiac Markers
5.6 Infectious Diseases
5.7 Primary Care Systems (Includes Lipid)
5.8 Hematology
5.9 Decentralized Clinical Chemistry
5.10 Feces
5.11 Blood Gas/Electrolytes
5.12 Ambulatory Chemistry
5.13 Urinalysis
5.14 Drug Abuse Testing
Chapter 6. Point of Care (PoC) Diagnostics Market Assessment by Infectious Diseases
6.1 Introduction
6.2 HIV POC
6.3 Clostridium difficile POC
6.4 HBV POC
6.5 Pneumonia or Streptococcus associated infections
6.6 Respiratory syncytial virus (RSV) POC
6.7 HPV POC
6.8 Influenza/Flu POC
6.9 HCV POC
6.10 MRSA POC
6.11 TB & drug-resistant TB POC
6.12 HSV POC
6.13 Other Infectious Diseases
Chapter 7. Point of Care (PoC) Diagnostics Market Assessment by End-Use
7.1 Introduction
7.2 Clinics
7.3 Hospitals
7.4 Home
7.5 Assisted Living Healthcare Facilities
7.6 Laboratory
7.7 Other End-Uses
Chapter 8. Point of Care (PoC) Diagnostics Market Assessment by Mode of Prescription
8.1 Introduction
8.2 OTC
8.3 Prescription-based
Chapter 9. Point of Care (PoC) Diagnostics Market Assessment by Region
9.1 Introduction
9.2 Point of Care (PoC) Diagnostics Market – North America
9.2.1 Point of Care (PoC) Diagnostics Market – U.S.
9.2.2 Point of Care (PoC) Diagnostics Market – Canada
9.3 Point of Care (PoC) Diagnostics Market – Europe
9.3.1 Point of Care (PoC) Diagnostics Market – Germany
9.3.2 Point of Care (PoC) Diagnostics Market – France
9.3.3 Point of Care (PoC) Diagnostics Market – UK
9.3.4 Point of Care (PoC) Diagnostics Market – Italy
9.3.5 Point of Care (PoC) Diagnostics Market – Spain
9.4 Point of Care (PoC) Diagnostics Market – Asia Pacific
9.4.1 Point of Care (PoC) Diagnostics Market – Japan
9.4.2 Point of Care (PoC) Diagnostics Market – China
9.4.3 Point of Care (PoC) Diagnostics Market – India
9.4.4 Point of Care (PoC) Diagnostics Market – South Korea
9.4.5 Point of Care (PoC) Diagnostics Market – Singapore
9.4.6 Point of Care (PoC) Diagnostics Market – Australia
9.5 Point of Care (PoC) Diagnostics Market – Latin America
9.5.1 Point of Care (PoC) Diagnostics Market – Brazil
9.5.2 Point of Care (PoC) Diagnostics Market – Mexico
9.5.3 Point of Care (PoC) Diagnostics Market – Chile
9.5.4 Point of Care (PoC) Diagnostics Market – Argentina
9.6 Point of Care (PoC) Diagnostics Market – Middle East & Africa
9.6.1 Point of Care (PoC) Diagnostics Market – Saudi Arabia
9.6.2 Point of Care (PoC) Diagnostics Market – UAE
9.6.3 Point of Care (PoC) Diagnostics Market – South Africa
9.6.4 Point of Care (PoC) Diagnostics Market – Nigeria
9.6.5 Point of Care (PoC) Diagnostics Market – Qatar
9.6.6 Point of Care (PoC) Diagnostics Market – Kenya
9.6.7 Point of Care (PoC) Diagnostics Market – Zimbabwe
Chapter 10. Competitive Landscape
10.1 Product Launch and Acquisition Are the Best Adopted Strategy by the Companies
10.2 Expansion
10.3 Product Launch
10.4 Partnerships/Collaborations/Agreements/Exhibitions
Chapter 11. Company Profiles
11.1 Abbott
11.1.1 Business Overview
11.1.2 Financial Snapshot
11.1.3 Products and Services
11.1.4 Recent Developments
11.2 BD
11.2.1 Business Overview
11.2.2 Financial Snapshot
11.2.3 Products and Services
11.2.4 Recent Developments
11.3 bioMérieux
11.3.1 Business Overview
11.3.2 Financial Snapshot
11.3.3 Products and Services
11.3.4 Recent Developments
11.4 Danaher Corporation
11.4.1 Business Overview
11.4.2 Financial Snapshot
11.4.3 Products and Services
11.4.4 Recent Developments
11.5 EKF Diagnostics Holdings plc
11.5.1 Business Overview
11.5.2 Financial Snapshot
11.5.3 Products and Services
11.5.4 Recent Developments
11.6 F. Hoffmann-La Roche Ltd
11.6.1 Business Overview
11.6.2 Financial Snapshot
11.6.3 Products and Services
11.6.4 Recent Developments
11.7 Quest Diagnostics Incorporated
11.7.1 Business Overview
11.7.2 Financial Snapshot
11.7.3 Products and Services
11.7.4 Recent Developments
11.8 QuidelOrtho Corporation
11.8.1 Business Overview
11.8.2 Financial Snapshot (Abbott Lab.)
11.8.3 Products and Services
11.8.4 Recent Developments
11.9 Siemens Healthcare Private Limited
11.9.1 Business Overview
11.9.2 Financial Snapshot
11.9.3 Products and Services
11.9.4 Recent Developments
11.10 Thermo Fisher Scientific Inc
11.10.1 Business Overview
11.10.2 Financial Snapshot
11.10.3 Products and Services
11.10.4 Recent Developments
11.11 Nova Biomedical
11.11.1 Business Overview
11.11.2 Products and Services
11.11.3 Recent Developments
11.12 HemoCue AB
11.12.1 Business Overview
11.12.2 Financial Snapshot
11.12.3 Products and Services
11.13 International Technidyne Corporation (ITC)
11.13.1 Business Overview
11.13.2 Products and Services
11.14 Quidel Corporation
11.14.1 Business Overview
11.14.2 Financial Snapshot
11.14.3 Products and Services
11.15 Trinity Biotech PLC
11.15.1 Business Overview
11.15.2 Financial Snapshot
11.15.3 Products and Services
11.16 Sekisui Diagnostics LLC
11.16.1 Business Overview
11.16.2 Financial Snapshot
11.16.3 Products and Services
11.16.4 Recent Developments
11.17 OraSure Technologies Inc.
11.17.1 Business Overview
11.17.2 Financial Snapshot
11.17.3 Products and Services
11.17.4 Recent Developments
11.18 Spectral Diagnostics
11.18.1 Business Overview
11.18.2 Financial Snapshot
11.18.3 Products and Servicesovid
11.18.4 Recent Developments
11.19 PTS Diagnostics
11.19.1 Business Overview
11.19.2 Products and Services

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us